3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
18
Burkitt Lymphoma
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Smoldering Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Leukemia
2
Immunoglobulin Light-chain Amyloidosis
2
Down Syndrome
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Leukemia, Plasma Cell
1
Leukemia, Hairy Cell
1
Leukemia, Biphenotypic, Acute
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Brain Neoplasms
1
Anus Neoplasms
1
Ann Arbor Stage II Mantle Cell Lymphoma
1
Interventions
Injections
5
pembrolizumab
2
Pemetrexed
2
Carboplatin
2
tislelizumab
1
sotorasib
1
sacituzumab govitecan
1
fludarabine
1
WW Domain-Containing Oxidoreductase
1
SYS6006 COVID-19 vaccine
1
Panitumumab
1
Paclitaxel
1
Oxaliplatin
1
Leucovorin
1
Immune Checkpoint Inhibitors
1
Fluorouracil
1
Drug Therapy
1
Cetuximab
1
Antiemetics
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumors
×
Calcium Dobesilate
×
30 days
×
Clear all
No trials found.